Strohm, the maker of thermoplastic composite pipes (TCP), has launched its TCP Designer — a new web-based tool developed to help companies design and engineer TCPs for their projects.

including Blueprint Medicines Corporation’s promising pipeline and financial strength. The company’s recent corporate update highlighted significant milestones and potential market ...

The soil on every inch of the pipeline would be tested to figure out which design worked best. The designers determined that they pipe could be buried in three types of ground: permanently thawed ...

The deal with Blueprint Medicines for BLU-782, an ALK2 inhibitor class drug, builds on Ipsen’s acquisition of the Canadian rare diseases biotech Clementia Pharmaceuticals for up to $1.31 billion ...

While Ayvakit remains the primary driver of Blueprint Medicines' current success, the company's pipeline holds promise for future growth. Of particular interest is BLU-808, an oral wild-type KIT ...